Literature DB >> 9951917

Chronic liver diseases for the risk of hepatocellular carcinoma: a case-control study in Japan. Etiologic association of alcohol consumption, cigarette smoking and the development of chronic liver diseases.

M Mukaiya1, M Nishi, H Miyake, K Hirata.   

Abstract

BACKGROUND/AIMS: A great number of hepatocellular carcinoma (HCC) develop from chronic liver disease. Among a total of 23,000 deaths of HCC in 1988 in Japan, 82% had positive antibodies against HBV and/or HCV. In the present study we investigated the etiological factors involved in this process, employing patients with chronic hepatitis as controls.
METHODOLOGY: In this study, alcohol consumption and cigarette smoking were investigated in 104 male patients with HCC which developed from chronic liver disease and 104 male controls with chronic liver disease without HCC (one for each case) matched for age.
RESULTS: When compared with non-drinkers and non-smokers, the relative risk (RR) for developing HCC rose to 17.9 among those with both drinking and smoking habits. The risk was greater than for those in whom either habit existed alone. The RR decreased among ex-smokers who were non-drinkers or ex-drinkers, but it was still as high as 9.4. For current smokers, even if they were non- or ex-drinkers, the RR was 15.4.
CONCLUSIONS: Drinking and the cigarette smoking were both risk factors, but the existence of synergism between them was also suggested. Therefore, patients with chronic liver disease should be thoroughly counseled to refrain from both drinking and smoking.

Entities:  

Mesh:

Year:  1998        PMID: 9951917

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  15 in total

1.  Smoking and Liver Disease.

Authors:  Stephanie M Rutledge; Amon Asgharpour
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-12

Review 2.  Heavy smoking and liver.

Authors:  Abdel-Rahman El-Zayadi
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

Review 3.  Conceptual importance of identifying alcoholic liver disease as a lifestyle disease.

Authors:  Hidekazu Tsukamoto
Journal:  J Gastroenterol       Date:  2007-08-24       Impact factor: 7.527

4.  Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma.

Authors:  C Rabe; T Pilz; C Klostermann; M Berna; H H Schild; T Sauerbruch; W H Caselmann
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

5.  Analyzing the Impact of Increasing Mechanical Index and Energy Deposition on Shear Wave Speed Reconstruction in Human Liver.

Authors:  Yufeng Deng; Mark L Palmeri; Ned C Rouze; Stephen J Rosenzweig; Manal F Abdelmalek; Kathryn R Nightingale
Journal:  Ultrasound Med Biol       Date:  2015-04-18       Impact factor: 2.998

Review 6.  The global epidemiology of hepatocellular carcinoma: present and future.

Authors:  Katherine A McGlynn; W Thomas London
Journal:  Clin Liver Dis       Date:  2011-05       Impact factor: 6.126

7.  Depression and cigarette smoking independently relate to reduced health-related quality of life among Canadians living with hepatitis C.

Authors:  Louise Balfour; Curtis Cooper; John Kowal; Giorgio A Tasca; Amy Silverman; Marie Kane; Gary Garber
Journal:  Can J Gastroenterol       Date:  2006-02       Impact factor: 3.522

8.  Impact of cigarette smoking on response to interferon therapy in chronic hepatitis C Egyptian patients.

Authors:  A El-Zayadi; Osaima Selim; H Hamdy; A El-Tawil; Hanaa-M Badran; M Attia; A Saeed
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

9.  Impact of hepatitis C virus infection on lifestyle.

Authors:  Paola Scognamiglio; Vincenzo Galati; Assunta Navarra; Maria Antonella Longo; Maria Stella Aloisi; Maria Giulia Antonini; Massimo Puoti; Piero Luigi Almasio; Giuseppe Ippolito; Enrico Girardi
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

10.  Therapeutic challenges in hepatitis C-infected injection drug using patients.

Authors:  Curtis L Cooper; Edward J Mills
Journal:  Harm Reduct J       Date:  2006-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.